Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonhuman primate models for HIV vaccine development.

N L Letvin1

  • 1Harvard Medical School, New England Regional Primate Research Center, Southborough, MA 01722.

Immunodeficiency Reviews
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Airway CD8(+) T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity.

Mucosal immunology·2012
Same author

Systemic vaccination induces clonally diverse SIV-specific CD8+ T-cell populations in systemic and mucosal compartments.

Mucosal immunology·2012
Same author

A vaccine that delivers rather than induces antibodies.

Gene therapy·2009
Same author

Intestinal stromal tumors in a simian immunodeficiency virus-infected, simian retrovirus-2 negative rhesus macaque (Macaca mulatta).

Veterinary pathology·2005
Same author

Variable NKG2 expression in the peripheral blood lymphocytes of rhesus monkeys.

Clinical and experimental immunology·2004
Same author

Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.

Journal of virology·2004
Same journal

Severe combined immunodeficiencies.

Immunodeficiency reviews·1992
Same journal

Molecular basis of the autosomal recessive forms of chronic granulomatous disease.

Immunodeficiency reviews·1992
Same journal

Inherited deficiencies of the terminal components of human complement.

Immunodeficiency reviews·1992
Same journal

Immunodeficiency with hyper-IgM (HIM).

Immunodeficiency reviews·1992
Same journal

Primary immunodeficiency diseases. Report of a WHO scientific group.

Immunodeficiency reviews·1992
Same journal

Gene therapy for primary immunodeficiency disease.

Immunodeficiency reviews·1992
See all related articles

Animal models are crucial for developing human immunodeficiency virus (HIV) vaccines. Current nonhuman primate models show promise but require further development to achieve long-lasting immunity against various forms of HIV challenge.

Area of Science:

  • Veterinary Medicine
  • Immunology
  • Virology

Background:

  • Human immunodeficiency virus (HIV) infection remains a global health challenge.
  • Animal models, particularly nonhuman primates, are vital for studying HIV pathogenesis and vaccine development.
  • While HIV-1 infects great apes without causing disease, some Simian Immunodeficiency Virus (SIV) strains induce an AIDS-like illness in macaques.

Purpose of the Study:

  • To evaluate the utility of animal models, specifically the SIV/macaque model, for advancing HIV vaccine research.
  • To assess the effectiveness of current vaccine strategies in nonhuman primate models.
  • To identify limitations and future directions for achieving robust and long-lasting immunity against HIV.

Main Methods:

  • Utilizing Simian Immunodeficiency Virus (SIV) infection in macaque monkeys as a model system.

Related Experiment Videos

  • Assessing various vaccine approaches in nonhuman primates.
  • Evaluating the immune response and protective efficacy against different types of viral challenge (cell-free, cell-associated, mucosal).

    • Main Results:

    • Nonhuman primate models have demonstrated that current vaccine strategies can induce transient immunity.
    • This immunity has shown protection against limited intravenous challenges with cell-free virus.
    • Achieving long-standing immunity that protects against cell-associated or mucosal virus challenge has not yet been accomplished.

    Conclusions:

    • The SIV/macaque model is a valuable tool for understanding AIDS pathogenesis and testing HIV vaccine candidates.
    • Current vaccine approaches in nonhuman primates offer partial and temporary protection.
    • Further research and development using nonhuman primate models are essential to achieve durable immunity and effective HIV vaccines.